204 related articles for article (PubMed ID: 22527886)
1. Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.
Eaton A; Nagy E; Pacault M; Fauconnier J; Bäck M
J Mol Med (Berl); 2012 Oct; 90(10):1223-31. PubMed ID: 22527886
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
Kamohara M; Takasaki J; Matsumoto M; Matsumoto Si ; Saito T; Soga T; Matsushime H; Furuichi K
Biochem Biophys Res Commun; 2001 Oct; 287(5):1088-92. PubMed ID: 11587533
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
5. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
6. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor.
Carnini C; Accomazzo MR; Borroni E; Vitellaro-Zuccarello L; Durand T; Folco G; Rovati GE; Capra V; Sala A
FASEB J; 2011 Oct; 25(10):3519-28. PubMed ID: 21753081
[TBL] [Abstract][Full Text] [Related]
8. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
10. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
[TBL] [Abstract][Full Text] [Related]
11. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
14. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
15. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
16. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis.
Azari BM; Marmur JD; Salifu MO; Cavusoglu E; Ehrlich YH; Kornecki E; Babinska A
Atherosclerosis; 2010 Sep; 212(1):197-205. PubMed ID: 20627246
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptors in atherosclerosis.
Bäck M; Hansson GK
Ann Med; 2006; 38(7):493-502. PubMed ID: 17101540
[TBL] [Abstract][Full Text] [Related]
18. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of human cysteinyl leukotriene 1 receptor gene structure.
Woszczek G; Pawliczak R; Qi HY; Nagineni S; Alsaaty S; Logun C; Shelhamer JH
J Immunol; 2005 Oct; 175(8):5152-9. PubMed ID: 16210619
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene 1 receptors as novel mechanosensors mediating myogenic tone together with angiotensin II type 1 receptors-brief report.
Storch U; Blodow S; Gudermann T; Mederos Y Schnitzler M
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):121-6. PubMed ID: 25395620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
